Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Maxillofacial Plastic and Reconstructive Surgery
Published in: Maxillofacial Plastic and Reconstructive Surgery 1/2019

Open Access 01-12-2019 | Bruxism | Review

Application of botulinum toxin in maxillofacial field: Part III. Ancillary treatment for maxillofacial surgery and summary

Authors: Kyung-Hwan Kwon, Kyung Su Shin, Sung Hee Yeon, Dae Gun Kwon

Published in: Maxillofacial Plastic and Reconstructive Surgery | Issue 1/2019

Login to get access

Abstract

Botulinum toxin (BTX) has various therapeutic indications: bruxism, square jaw, facial wrinkle, oral ulcer and maxillofacial pain, etc. In this paper, we will discuss the effectiveness of using BTX in dental implant surgery and orthognathic and orthodontic treatment. We summarized the clinical application of botulinum toxin in the maxillofacial field at the finale.
Literature
1.
Adler CH (2009) Perioperative use of botulinum toxins. Toxicon 54:654–657CrossRef
2.
Gapski R, Wang HL, Mascarenhas P, Lang NP (2003) Critical review of immediate implant loading. Clin Oral Implants Res 14:515–527CrossRef
3.
Ihde S (2007) Prophylactic use of botulinum toxin in dental implantology. CMF Implement Dir 1:29–34
4.
Majid OW (2010) Clinical use of botulinum toxins in oral and maxillofacial surgery. Int J Oral Maxillofac Surg 39:197–207CrossRef
5.
Richter EJ, Orschall B, Jovanovic SA (1990) Dental implant abutment resembling the two-phase tooth mobility. J Biomech 23:297–306CrossRef
6.
Isidor F (2006) Influence of forces on peri-implant bone. Clin Oral Implants Res 17:8–18CrossRef
7.
Duyck J, Van Oosterwyck H, Vander Sloten J, De Cooman M, Puers R, Naert I (2000) Magnitude and distribution of occlusal forces on oral implants supporting fixed prostheses: an in vivo study. Clin Oral Implants Res 11:465–475CrossRef
8.
Mann AW, Pankey LD (1963) The Pankey Mann philosophy of occlusal rehabilitation. Dent Clin N Am 7:621–638
9.
al-Quran FA, Lyons MF (1999) The immediate effect of hard and soft splints on the EMG activity of the masseter and temporalis muscles. J Oral Rehabil 26:559–563CrossRef
10.
To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC (2001) A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement Br. J Plat Surg 54:197–200CrossRef
11.
Albrektsson T, Albrektsson B (1987) Osseointegration of bone implants. A review of an alternative mode of fixation. Acta Orthop Scand 58:567–577CrossRef
12.
Sagara M, Akagawa Y, Nikai H, Tsuru H (1993) The effects of early occlusal loading on one-stage titanium alloy implants in beagle dogs: a pilot study. J Prosthet Dent 69:281–288CrossRef
13.
Balshi TJ, Wolfinger GJ (1997) Immediate loading of Brånemark implants in edentulous mandibles: a preliminary report. Implant Dent 6:83–88CrossRef
14.
Ganeles J, Rosenberg MM, Holt RL, Reichman LH (2001) Immediate loading of implants with fixed restorations in the completely edentulous mandible: report of 27 patients from a private practice. Int J Oral Maxillofac Implants 16:418–426PubMed
15.
Colomina LE (2001) Immediate loading of implant-fixed mandibular prostheses: a prospective 18-month follow-up clinical study--preliminary report. Implant Dent 10:23–29CrossRef
16.
Kerner JC (1817) Vergiftung durch verdorbene Wuerste. Tuebinger Blaetter Naturwissenschaften Arznykunde 3:1–45
17.
Van Ermengen E (1897) Ueber einen neuen anaeroben Bacillus und seine Beziehung zum Botulismus. J Hyg Infektionskrankh 26:1–56
18.
Schantz EJ, Johnson EA (1997) Botulinumtoxin the story of its development of human disease. Perspect Biol Med 40:317–327CrossRef
19.
BURGEN AS, DICKENS F, ZATMAN LJ (1949) The action of botulinum toxin on the neuromuscular junction. J Physiol 109:10–24CrossRef
20.
Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Opthalmol 12:924–927
21.
Scott AB (1989) Clostridial toxins as therapeutic agents. In: Simpson LL (ed) Botulinum neurotoxin and tetanus toxin. Academic, New York
22.
Carruthers J, Carruthers A (1991) Botulinum toxin use on Glabells wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery, Orlando 13-17 March 1991
23.
Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-a exotoxin. J Dermatol Surg Oncol 18:17–21CrossRef
24.
Greene PE, Fahn S (1996) Response to botulinum toxin F in seronegative botulinum toxin a resistant patients. Mov Disord 11:181–184CrossRef
25.
Das Gupta BR, Sugiyama H (1977) Biochemistry and pharmacology of botulinum and tetanus neurotoxins. In: Bernheimer AW (ed) Perspectives in toxicology. Wiley, New York
26.
Becker-Wegerich P, Rauch L, Ruzicka T (2001) Botulinum toxin A in the therapy of mimic facial lines. Clin Exp Dermatol 26:619–630CrossRef
27.
Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plast Surg 25:73–84CrossRef
28.
Borodic G, Johnson E, Goodnough M, Schantz E (1996) Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 46:26–29CrossRef
29.
Dressler D (2012) Clinical application of botulium toxin therapy. Curr Opin Microbiol 15:325–336CrossRef
30.
Kwon TG (2016) Botulinum toxin related research in maxillofacial plastic and reconstructive surgery. Maxillofac Plast Reconstr Surg 38:34CrossRef
31.
Kim SY, Kim YK, Yun PY, Bae JH (2018) Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study. Maxillofac Plast Reconstr Surg 40:21CrossRef
Metadata
Title
Application of botulinum toxin in maxillofacial field: Part III. Ancillary treatment for maxillofacial surgery and summary
Authors
Kyung-Hwan Kwon
Kyung Su Shin
Sung Hee Yeon
Dae Gun Kwon
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Maxillofacial Plastic and Reconstructive Surgery / Issue 1/2019
Electronic ISSN: 2288-8586
DOI
https://doi.org/10.1186/s40902-019-0226-0

Other articles of this Issue 1/2019

Maxillofacial Plastic and Reconstructive Surgery 1/2019 Go to the issue

Case report

Condyle dislocation following mandibular reconstruction using a fibula free flap: complication cases

Review

Current status of surgery first approach (part II): precautions and complications

Research

Botulinum toxin A injection into the anterior belly of the digastric muscle increased the posterior width of the maxillary arch in developing rats

Case report

Sialolithotomy of the submandibular duct using sialendoscopy

Research

The preliminary study for three-dimensional alveolar bone morphologic characteristics for alveolar bone restoration

Research

A clinico-radiographic and histomorphometric analysis of alveolar ridge preservation using calcium phosphosilicate, PRF, and collagen plug